Literature DB >> 35946776

Comment on: "Evaluating treatment options in managing thyroid nodules with indeterminate cytology of TBSRTC in thyroidology: addendum aut non?"

Ilker Sengul1,2, Demet Sengul3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35946776      PMCID： PMC9574958          DOI： 10.1590/1806-9282.20220383

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN： 0104-4230            Impact factor:   1.712


× No keyword cloud information.
  6 in total

1.  The Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  The 2017 Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2017-11       Impact factor: 6.568

4.  Treatment Choices in Managing Bethesda III and IV Thyroid Nodules: A Canadian Multi-institutional Study.

Authors:  Victoria Kuta; David Forner; Jason Azzi; Dennis Curry; Christopher W Noel; Kelti Munroe; Martin Bullock; Ted McDonald; S Mark Taylor; Matthew H Rigby; Jonathan Trites; Stephanie Johnson-Obaseki; Martin J Corsten
Journal:  OTO Open       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.